Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance)

Author:

Klepin Heidi D.1,Pitcher Brandelyn N.1,Ballman Karla V.1,Kornblith Alice B.1,Hurria Arti1,Winer Eric P.1,Hudis Clifford1,Cohen Harvey J.1,Muss Hyman B.1,Kimmick Gretchen G.1

Affiliation:

1. Wake Forest School of Medicine, Winston-Salem; Alliance Statistics and Data Center, Duke University; Duke University Medical Center, Durham; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Dana Farber Cancer Institute, Boston, MA; City of Hope National Medical Center, Duarte, CA; and Memorial Sloan Kettering Cancer Center, New York, NY

Abstract

Comorbidity was associated with shorter overall survival but not toxicity or relapse among older women with breast cancer with good functional status.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3